Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Shepherd: Effect of lowering LDL cholesterol substantially below currently recommended levels.... (0.12 sec) 

Effect of lowering LDL cholesterol substantially below currently recommended levels in …

- diabetesjournals.org
J Shepherd, P Barter, R Carmena, P Deedwania … - Diabetes Care, 2006 - Am Diabetes Assoc
RESULTS—End-of-treatment mean LDL cholesterol levels were 98.6 mg/dl with
atorvastatin 10 mg and 77.0 mg/dl with atorvastatin 80 mg. A primary event
occurred in 135 patients (17.9%) receiving atorvastatin 10 mg, compared ...
Cited by 133 - Related articles - BL Direct - All 6 versions

Effect of Lowering LDL Cholesterol Substantially Below Currently Recommended Levels in …


FD Care - medscape.com
The Treating to New Targets (TNT) study [16] was designed to provide more
information on the optimal level of LDL cholesterol for cardiovascular risk
reduction in patients with established CHD. Reduction to a mean LDL ...
Related articles - All 5 versions

Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in …

- Free from Publisher
RH Knopp - Diabetes Care, 2006 - Am Diabetes Assoc
We mention in our article the high rates of treatment “drop in” and “drop
out” and the potential impact on the primary end point (mostly due to changing
guidelines and study design changes). While Gazi and Mikhailidis correctly ...
Cited by 100 - Related articles - BL Direct - All 8 versions

Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 …

- diabetesjournals.org [PDF] 
NR Poulter, PS Sever, B Dahlof, H Wedel… - Diabetes Care, 2005 - Am Diabetes Assoc
Glial cell line–derived neurotrophic factor (GDNF) belongs to the neu-
rotrophic factor family. GDNF functions are not restricted to neurons but are
also implicated in glial cell develop- ment (1). We observed high ...
Cited by 171 - Related articles - BL Direct - All 12 versions

Acute coronary syndromes and diabetes: is intensive lipid lowering beneficial? Results of …

- oxfordjournals.org
S Ahmed, CP Cannon, SA Murphy, E … - European heart journal, 2006 - Eur Soc Cardiology
Methods and results We explored this question in data from the Pravastatin or
Atorvastatin Evaluation and Infection Therapy (PROVE IT) TIMI 22 trial, which
tested standard (pravastatin 40 mg) vs. intensive (atorvastatin 80 mg) ...
Cited by 23 - Related articles - BL Direct - All 6 versions

Beta cell dysfunction in patients with acute myocardial infarction but without previously …


M Wallander, M Bartnik, S Efendic, A Hamsten, … - Diabetologia, 2005 - Springer
Page 1. Diabetologia (2005) 48: 2229–2235 DOI 10.1007/s00125-005-1931-z ARTICLE
M. Wallander . M. Bartnik . S. Efendic . A. Hamsten . K. Malmberg . ...
Cited by 36 - Related articles - BL Direct - All 3 versions

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

- umn.edu [PDF] 
JC LaRosa, SM Grundy, DD Waters, C Shear, P … - New England Journal of Medicine, 2005 - content.nejm.org
From the State University of New York Health Science Center, Brooklyn (JCL); the
University of Texas Southwestern Medical Center, Dallas (SMG); San Francisco
Gen- eral Hospital, San Francisco (DDW); Pfizer, Groton, Conn. (CS); the ...
Cited by 1534 - Related articles - BL Direct - All 41 versions

Prevalence and control of dyslipidemia among persons with diabetes in the United States


MJ Jacobs, T Kleisli, JR Pio, S Malik, GJ L' … - Diabetes research and clinical practice, 2005 - Elsevier
: Less than one-third of men and only one-fifth of women with diabetes are in
control for LDL-C, defined as <2.6 mmol/l (<100 mg/dl); over 70% are not at
goal. Over half of men and over two-thirds of women have low levels of ...
Cited by 39 - Related articles - All 10 versions

[CITATION] Treatment decisions in stable coronary artery disease in a broad range of European …


A Breeman, M Hordijk, M Lenzen… - J Thorac Cardiovasc Surg, 2006
Cited by 10 - Related articles

Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and …

- lipidgeneticsclinic.ca [PDF] 
P Deedwania, P Barter, R Carmena, JC … - The Lancet, 2006 - Elsevier
The TNT study was a prospective, double blind, parallel-group trial done at 256
sites in 14 countries between April, 1998, and August, 2004, with a median
follow-up of 4·9 years. 10 001 patients were enrolled aged 35–75 years ...
Cited by 109 - Related articles - All 11 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google